Clinical Trial

Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

Study acronym: LUPINE
Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This clinical trial is designed to compare and evaluate the efficacy and safety of the combination therapy of Lurbinectedin plus Paclitaxel (Combination Arm) versus Paclitaxel monotherapy (Monotherapy Arm) in patients with extensive-stage small-cell lung cancer whose disease has progressed after first-line chemotherapy.
Trial Details
NCT Number NCT07640932
Lead Sponsor Yonsei University
Conditions Carcinoma, Small Cell Lung
Enrollment 69 participants
Start Date 2026-06
Primary Completion 2027-04 (estimated)
Study Completion 2029-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-11